Drug intelligence / Profile preview

sodium chloride + magnesium chloride + sodium acetate anhydrous + sodium gluconate + potassium chloride

Development stage
Unknown
Lead developer
Baxter Healthcare Corporation
Modality
Small Molecules
Administration
Intravenous, Parenteral
01

Overview

sodium chloride + magnesium chloride + sodium acetate anhydrous + sodium gluconate + potassium chloride is a sterile, nonpyrogenic, isotonic intravenous electrolyte solution used for fluid and electrolyte replacement. Marketed under brand names including Normosol-R and Plasma-Lyte A, it is designed to approximate the principal ionic composition of normal human plasma and is used to replace acute extracellular fluid losses, including in surgery, trauma, burns, shock, and moderate blood loss. Its pharmacologic effect is not receptor-mediated; rather, it expands the extracellular fluid compartment and replenishes sodium, potassium, magnesium, chloride, acetate, and gluconate ions. Acetate and gluconate function as bicarbonate precursors that help buffer acid-base status. It is an inorganic salt combination product developed and manufactured by companies including Pfizer and Baxter for hospital intravenous use.

Brand names
Normosol-RPlasma-Lyte A
Other names
multiple electrolytes injectionmulti-electrolyte intravenous injection solution

Beyond the preview

Go deeper on sodium chloride + magnesium chloride + sodium acetate anhydrous + sodium gluconate + potassium chloride.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sodium chloride + magnesium chloride + sodium acetate anhydrous + sodium gluconate + potassium chloride.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call